Roger Abramino Levy (Roger A Levy)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Gestational Age

Tyrosine Kinase

Systemic Lupus Erythematosus

Top Venues

Lupus science & medicine

Annals of the rheumatic diseases

Arthritis care & research

This page only lists publications with an associated author ORCID identifier.

Publications

Anca D Askanase, Richard A Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting, Ming-Hui Zhao, Ian N Bruce, Munther Khamashta, Bernie Rubin, Angela Carroll, Mark Daniels, Roger Abramino Levy, Ronald F Van Vollenhoven, Murray B Urowitz
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations. Lupus science & medicine 11 (1) (2024)
Anca D Askanase, Richard A Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting, Ming-Hui Zhao, Ian N Bruce, Munther Khamashta, Bernie Rubin, Angela Carroll, Mark Daniels, Roger Abramino Levy, Ronald F Van Vollenhoven, Murray B Urowitz
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations. Lupus science & medicine 11 (1) (2024)
Anca D Askanase, Richard A Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting, Ming-Hui Zhao, Ian N Bruce, Munther Khamashta, Bernie Rubin, Angela Carroll, Mark Daniels, Roger Abramino Levy, Ronald F Van Vollenhoven, Murray B Urowitz
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations. Lupus science & medicine 11 (1) (2024)
Anca D Askanase, Richard A Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting, Ming-Hui Zhao, Ian N Bruce, Munther Khamashta, Bernie Rubin, Angela Carroll, Mark Daniels, Roger Abramino Levy, Ronald F Van Vollenhoven, Murray B Urowitz
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations. Lupus science & medicine 11 (1) (2024)
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle A Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger Abramino Levy, Deven Chauhan, Nick Ballew
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. Lupus science & medicine 10 (1) (2023)
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle A Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger Abramino Levy, Deven Chauhan, Nick Ballew
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. Lupus science & medicine 10 (1) (2023)
Medha Barbhaiya, Stéphane Zuily, Ray Naden, Alison Hendry, Florian Manneville, Mary-Carmen Amigo, Zahir Amoura, Danieli Castro de Oliveira Andrade, Laura Andreoli, Bahar Artim-Esen, Tatsuya Atsumi, Tadej Avcin, H Michael Belmont, Maria Laura Bertolaccini, D Ware Branch, Graziela Carvalheiras, Alessandro Casini, Ricard Cervera, Hannah Cohen, Nathalie Costedoat-Chalumeau, Mark Crowther, Guilherme Ribeiro Ramires de Jésus, Aurelien Delluc, Sheetal Desai, Maria De Sancho, Katrien M Devreese, Reyhan Diz-Kucukkaya, Ali Duarte Garcia, Camille Frances, David Garcia, Jean-Christophe Gris, Natasha Jordan, Rebecca K Leaf, Nina Kello, Christian Lood, Carl Laskin, Alfred I Lee, Kimberly Legault, Steve R Levine, Roger Abramino Levy, Maarten Limper, Michael D Lockshin, Karoline Mayer-Pickel, Jack Musial, Pier Luigi Meroni, Giovanni Orsolini, Thomas L Ortel, Vittorio Pengo, Michelle A Petri, Guillermo J Pons-Estel, Jose A Gomez-Puerta, Quentin Raimboug, Robert Roubey, Giovanni Sanna, Surya V Seshan, Savinio Sciascia, Maria G G Tektonidou, Angela Tincani, Denis Wahl, Rohan Willis, Cécile Yelnik, Catherine Zuily, Francis Guillemin, Karen H Costenbader, Doruk Erkan, null null
2023 ACR/EULAR antiphospholipid syndrome classification criteria. Annals of the rheumatic diseases (2023)
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle A Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger Abramino Levy, Deven Chauhan, Nick Ballew
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. Lupus science & medicine 10 (1) (2023)
Ian N Bruce, Joy Jones Buie, Lauren Bloch, Sang-Cheol Bae, Karen Costenbader, Roger Abramino Levy, Victoria P Werth, Ashley Marion, Sanjyot Sangodkar, Susan Manzi
Lupus spectrum ambiguity has long-term negative implications for patients. Lupus science & medicine 10 (1) (2023)
Ken-Ei Sada, Noriaki Kurita, Hisashi Noma, Taizo Matsuki, Holly A Quasny, Roger Abramino Levy, Angela R Jones-Leone, Kerry Gairy, Nobuyuki Yajima
MOONLIGHT study: the design of a comparative study of the effectiveness of belimumab in patients with a history of lupus nephritis from the post-Marketed effectiveness of belimumab cOhOrt and JapaN Lupus NatIonwide reGistry (LUNA) coHorT. Lupus science & medicine 9 (1) (2023)
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle A Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger Abramino Levy, Deven Chauhan, Nick Ballew
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. Lupus science & medicine 10 (1) (2023)
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle A Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger Abramino Levy, Deven Chauhan, Nick Ballew
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. Lupus science & medicine 10 (1) (2023)
Michelle A Petri, Helain Landy, Megan E B Clowse, Kim Gemzoe, Munther Khamashta, Milena Kurtinecz, Roger Abramino Levy, Andrew Liu, Rebecca Marino, Paige Meizlik, Jeanne M Pimenta, Kelsey Sumner, Hugh Tilson, Mary Beth Connolly, Keele Wurst, Julia Harris, Holly A Quasny, Patricia Juliao, David A Roth
Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports. Annals of the rheumatic diseases (2022)
Ronald F Van Vollenhoven, Anca D Askanase, Andrew S Bomback, Ian N Bruce, Angela Carroll, Maria Dall'Era, Mark Daniels, Roger Abramino Levy, Andreas Schwarting, Holly A Quasny, Murray B Urowitz, Ming-Hui Zhao, Richard A Furie
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria. Lupus science & medicine 9 (1) (2022)
Jeanne M Pimenta, Jeffery L Painter, Kim Gemzoe, Roger Abramino Levy, Marcy Powell, Paige Meizlik, Gregory Powell
Identifying Barriers to Enrollment in Patient Pregnancy Registries: Building Evidence Through Crowdsourcing. JMIR formative research 6 (5) (2022)
Guilherme Ribeiro Ramires de Jésus, Marcela Ignacchiti Lacerda Ávila, B Costa Rodrigues, Flávia Cunha Dos Santos, Adriana Paulino do Nascimento, Luís Cristóvão Moraes Sobrino Porto, Nilson Ramires de Jésus, Roger Abramino Levy, Evandro Mendes Klumb
Soluble Flt-1, Placental Growth Factor, and Vascular Endothelial Growth Factor Serum Levels to Differentiate Between Active Lupus Nephritis During Pregnancy and Preeclampsia. Arthritis care & research 73 (5) (2021)
Marcela Ignacchiti Lacerda Ávila, Guilherme Ribeiro Ramires de Jésus, Flávia Cunha Dos Santos, Nilson Ramires de Jésus, Roger Abramino Levy, Evandro Mendes Klumb
The SLICC/ACR Damage Index (SDI) may predict adverse obstetric events in patients with systemic lupus erythematosus. Lupus 30 (12) (2021)